Closing Bell: Briacell Therapeutics Corp down on Thursday (BCT)

In trading today, shares of Briacell Therapeutics Corp opened at $1.23 and closed at $1.05. Intraday prices ranged from a low of $0.99 to a high of $1.23.

The price dipped -16.00% from the previous day's close of $1.25.

Today across North America, the TSX Composite closed -0.54% at 22726.76, the S&P 500 closed -1.39% at 5588.27, the Dow Jones Industrial Average closed 0.59% at 41198.08 and the Nasdaq Composite closed -2.77% at 17996.92.

Briacell Therapeutics Corp traded under BCT on the Toronto Stock Exchange (TSX).

Trading volume was 145,631 on 431 total trades. On average, Briacell Therapeutics Corp has traded 31,696 shares over the last 5-days and 9,256 year-to-date.

Trading across the entire TSX saw 1,017 price advancers against 4,222 declines and 91 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $0.99 (July 18,2024). Moreover, the shares have plummeted -87.72% in the last 52 weeks, while in 2024, they have shrunken -86.54%.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $22.86 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Briacell Therapeutics Corp is holding an average recommendation of "Strong Buy" from 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..